Literature DB >> 29435393

Spontaneous Pneumothoraces and Hemothoraces in Sarcomas.

Fatima Ezzeddine1, Shadia Jalal2.   

Abstract

Spontaneous pneumothoraces and hemothoraces are rare manifestations of sarcomas occurring more commonly in specific histologic types, chemotherapy and/or anti-angiogenic therapy. Early identification of spontaneous pneumothoraces and hemothoraces improves the clinical outcomes. In this article, we present a case series of three patients with soft tissue and bone sarcomas who developed spontaneous pneumothoraces and/or hemothoraces and discuss the current literature highlighting the evidence behind these complications.

Entities:  

Keywords:  hemothoraces; pazopanib; pneumothoraces; sarcomas

Year:  2017        PMID： 29435393      PMCID： PMC5796811          DOI： 10.7759/cureus.1905

Source DB:  PubMed          Journal:  Cureus        ISSN： 2168-8184


  7 in total

1.  Incidence of pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment.

Authors:  K Nakano; L Inagaki; J Tomomatsu; N Motoi; T Gokita; K Ae; T Tanizawa; T Shimoji; S Matsumoto; S Takahashi
Journal:  Clin Oncol (R Coll Radiol)       Date:  2014-03-12       Impact factor: 4.126

Review 2.  A comprehensive review of spontaneous pneumothorax complicating sarcoma.

Authors:  Jeffrey B Hoag; Michael Sherman; Quadeer Fasihuddin; Mark E Lund
Journal:  Chest       Date:  2010-04-09       Impact factor: 9.410

3.  Unusual cause of recurrent pneumothorax: excavated metastasis of osteosarcoma.

Authors:  G Le Garff; H Léna; F Corbineau; P Kerbrat; P Delaval
Journal:  Ann Thorac Surg       Date:  2001-12       Impact factor: 4.330

4.  Primary lung cancer complicated with pneumothorax.

Authors:  R S Lai; R P Perng; S C Chang
Journal:  Jpn J Clin Oncol       Date:  1992-06       Impact factor: 3.019

5.  Spontaneous pneumothorax. A complication of lung cancer?

Authors:  C A Steinhäuslin; J F Cuttat
Journal:  Chest       Date:  1985-11       Impact factor: 9.410

6.  Pneumothorax as a complication of combination antiangiogenic therapy in children and young adults with refractory/recurrent solid tumors.

Authors:  Rodrigo B Interiano; M Beth McCarville; Jianrong Wu; Andrew M Davidoff; John Sandoval; Fariba Navid
Journal:  J Pediatr Surg       Date:  2015-01-16       Impact factor: 2.545

7.  Risk factors for pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment: a single-institute analysis.

Authors:  Kenji Nakano; Noriko Motoi; Junichi Tomomatsu; Tabu Gokita; Keisuke Ae; Taisuke Tanizawa; Seiichi Matsumoto; Shunji Takahashi
Journal:  BMC Cancer       Date:  2016-09-23       Impact factor: 4.430
  7 in total
  1 in total

1.  Secondary spontaneous pneumothorax in patients with sarcoma treated with Pazopanib, a case control study.

Authors:  Bruce Sabath; Hasan A Muhammad; Amulya Balagani; David E Ost; Erik Vakil; Tahreem Ahmed; Macarena R Vial; Horiana B Grosu
Journal:  BMC Cancer       Date:  2018-10-01       Impact factor: 4.430
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.